[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100587139":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":29,"responsibleParty":48,"collaborators":20,"id":50,"slug":20,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":20,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":20,"enrollmentInfo":58,"targetDuration":20,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":20,"overallStatus":32,"whyStopped":20,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Dr. August Wolff GmbH & Co. KG Arzneimittel","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Test Product (P-001230\u002F2)","EXPERIMENTAL","Patients receive at least two applications of the test product P-001230\u002F2 in the application area every day. An additional washing product is used to clean the skin.",[13],"Other: Protective Balm",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"OTHER","Protective Balm","The test product will be applied in addition to an additional washing product in the test area.",[9],null,[22,26],{"name":23,"role":24,"phone":20,"phoneExt":20,"email":25},"Clarissa Masur","CONTACT","clarissa.masur@drwolffgroup.com",{"name":27,"role":24,"phone":20,"phoneExt":20,"email":28},"Vanessa Letmathe","vanessa.letmathe@drwolffgroup.com",[30],{"facility":31,"status":32,"city":33,"state":20,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Klinikum Dortmund","RECRUITING","Dortmund","33137","Germany","DE",{"type":38,"coordinates":39},"Point",[40,41],7.466,51.51494,{"lat":41,"lon":40},[44],{"name":45,"role":24,"phone":46,"phoneExt":20,"email":47},"Prof. Dr. Thomas Reinbold","+49 231 953 19320","Thomas.Reinbold@klinikumdo.de",{"type":49,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100587139",false,"NCT06924502","Testing the Protective and Caring Effect of a Water-in-oil Formulation in Patients Suffering From Urinary and\u002For Fecal Incontinence and Requiring Incontinence Care Products","Non-controlled, Exploratory, Single-arm Clinical Study With a Water-in-oil Emulsion to Test the Protecting and Caring Effect of the Formulation on 'Incontinence-care Product Requiring' Fecal and\u002For Urinary Incontinent Patients","Inclusion Criteria:\n\n* Patient is capable of understanding the information given to them and providing informed consent\n* 70 years of age and older\n* Patients with incontinence (fecal and\u002For urinary), requiring incontinence protection material\n* Skin type on Fitzpatrick scale: Between I to IV\n\nExclusion Criteria:\n\n* Current cancer treatment such as chemotherapy, irradiation\n* Documented allergies to skin care and \u002F or skin cleansing products\n* Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, etc. at the test area that could influence the investigation\n* Incontinence-associated dermatitis (IAD) stage \\>1a\n* Active skin disease at the test area\n* Any topical medication at the test area within the last 3 days prior to the start of the study and \u002F or hroughout te entire course of the study\n* Mini-Mental-Status-Test (MMST) \\\u003C 20","ALL","70 Years",{"count":59,"type":60},40,"ESTIMATED","INTERVENTIONAL",[63],"NA","The aim of this study is to test the protecting and caring effect of a protective balm on patients suffering from urinary and\u002For fecal incontinence and need incontinence care products.",[66,67],"Incontinence, Urinary","Incontinence, Fecal","2025-07-17",{"date":70,"type":71},"2025-07-18","ACTUAL",{"date":73,"type":71},"2025-06-06",{"date":75,"type":60},"2025-11",{"name":5,"class":6},1]